Filter
3374
Filtered Results: 3374
Text search:
national
drug
authority
Featured
Recommendations
310
New Publications
978
Language
Document type
No document type
2039
Studies & Reports
516
Guidelines
437
Manuals
160
Strategic & Response Plan
124
Fact sheets
33
Training Material
32
Situation Updates
19
Infographics
5
Resource Platforms
4
Online Courses
3
Brochures
2
Countries / Regions
India
174
Global
108
Kenya
102
Ethiopia
96
Uganda
94
Western and Central Europe
89
Nigeria
67
Liberia
66
South Africa
65
Ghana
62
Sierra Leone
55
Tanzania
55
Latin America and the Carribbean
51
Myanmar / Burma
51
Nepal
50
Zambia
50
Malawi
49
Bangladesh
48
Africa
43
Rwanda
41
Eastern Europe
36
Ukraine
35
Zimbabwe
31
Cambodia
31
South–East Asia Region
29
Namibia
29
Asia
28
Philippines
26
Lesotho
22
Congo, Democratic Republic of
19
Botswana
18
Syria
16
Indonesia
14
Eastern Europe and Central Asia
13
Senegal
12
Mozambique
12
South Sudan
12
Eswatini/ Swaziland
12
Venezuela
11
Burkina Faso
10
East and Southern Africa
10
Russia
10
Haiti
9
Germany
9
West and Central Africa
9
Middle East and North Africa
9
Brazil
9
Colombia
8
Albania
8
Guinea
8
Vietnam
8
Pakistan
8
Laos
7
USA
7
Tajikistan
6
Thailand
6
China
6
Cameroon
6
Afghanistan
6
Western Pacific Region
6
Georgia
6
Moldova
5
Sri Lanka
5
Sudan
5
Central African Republic
5
North Macedonia
4
Mexico
4
Jordan
4
Yemen
4
Iraq
4
Turkey
3
Benin
3
Iran
3
Fiji
3
Jamaica
3
Lebanon
3
Papua New Guinea
3
Palestine
3
Mali
3
Libya
3
Somalia
3
Timor Leste/ East Timor
2
El Salvador
2
Serbia
2
Chile
2
Kyrgyzstan
2
Uzbekistan
2
Peru
2
Morocco
2
Mongolia
2
Armenia
2
Hungary
2
Saudi Arabia
2
North America
2
United Kingdom
2
Portugal
2
Southern Africa
2
Bolivia
2
Argentina
2
Poland
2
Bhutan
2
North Korea
1
Switzerland
1
Australia
1
Kazakhstan
1
Canada
1
Estonia
1
Qatar
1
Bulgaria
1
Italy
1
Guinea-Bissau
1
Lithuania
1
Ireland
1
Paraguay
1
Gabon
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Spain
1
Belarus
1
Côte d’Ivoire / Ivory Coast
1
Egypt
1
Romania
1
Greece
1
Honduras
1
Angola
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
1278
Clinical Guidelines
329
Public Health
195
Women & Child Health
145
Key Resources
90
Pharmacy & Technologies
56
Capacity Building
49
Toolboxes
HIV
361
TB
312
Mental Health
281
AMR
205
COVID-19
149
Pharmacy
141
NTDs
99
Rapid Response
79
Caregiver
65
Ebola
58
Planetary Health
51
Refugee
49
NCDs
49
Conflict
45
Global Health Education
39
Disability
33
Polio
17
Zika
16
Natural Hazards
15
Specific Hazards
14
Cholera
14
Health Financing Toolbox
14
Social Ethics
5
Health Financing
1
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi...
Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline
recommended
This second edition of the Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline provides the most up to date technical guidance on mask use in community settings in the context of COVID-19.
In this edition, new information includes updated mask re...
The COVID-19 pandemic has impacted regular cardiovascular healthcare access and delivery. Service utilisation has declined, and excess cardiovascular mortality has been reported in several countries. We aim to estimate excess cardiovascular deaths in Chile during 2020.
In 2015, 5.9 million children under age five died (1). The major causes of child deaths globally are pneumonia, prematurity, intrapartum-related complications, neonatal sepsis, congenital anomalies, diarrhoea, injuries and malaria (2). Most of these diseases and conditions are at least partially cau...
Tuberculosis (TB) is the deadliest infectious disease in most low- and middle-income countries, claiming more than 4,000 lives each day. The unprecedented COVID-19 pandemic has seriously impacted people with pre-existing health conditions. People with TB are usually more vulnerable to other infectio...
Safe water, sanitation and hygiene (collectively known as WASH) are crucial for human health and well-being. Yet, millions of people globally lack adequate WASH services and consequently suffer from or are exposed to a multitude of preventable illnesses.
It summarizes guidance on how to manage – and when to refer – children and adolescents presenting with common complaints and conditions. It includes information to enable primary health care providers to coordinate the continued care of children and adolescents with long-term conditions and dise...
Front. Public Health, 30 April 2021 | https://doi.org/10.3389/fpubh.2021.628744
Int. J. Environ. Res. Public Health 2020, 17(23), 8849; https://doi.org/10.3390/ijerph17238849
The aim of building climate resilient and environmentally sustainable health care facilities is: (a) to enhance their capacity to protect and improve the health of their target communities in an unstable...
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from ...
This document aims to provide interim guidance for microbiology and virology experts, other laboratory professionals, laboratory managers, infectious disease programme managers, public health professionals and other stakeholders that provide primary, confirmatory or advanced testing for SARS-CoV-2, ...
The pandemic has emphasized the high risk of avoidable harm to patients, health workers, and the general public, and has identified a range of safety gaps across all core components of health systems at all levels.
The rapid review ‘Implications of the COVID-19 pandemic for patient safety’ ex...
The objective of Health in the Americas: Overview of the Region of the Americas in the Context of the COVID-19 Pandemic is to respond to the need to address important public health issues in an increasingly timely manner, while serving as a platform with a close focus on specific issues of regional ...
The World Health Organization (WHO) convened a meeting of the Technical Advisory Group on Buruli ulcer at its headquarters in Geneva, Switzerland on 25 to 27 March 2019
The purpose of this book is to provide an overview of Buruli ulcer (Mycobacterium ulcerans infection) for the medical and scientific communities and the general public alike.
An estimated 1.3 billion people – or 16% of global population worldwide – experience a significant disability today. Persons with disabilities have the right to the highest attainable standard of health as those without disabilities. However, the WHO Global report on health equity for persons w...
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031.
The technical bri...
This manual provides a framework for morbidity management and disability prevention of patients affected by NIDs and gives specific guidance for the proper care of patients suffering from chronic conditions caused by lymphatic filariasis, leprosy, trachoma, and Chagas disease. It is intended to be u...
This new guidance aims to support programme implementers, coordinators and others in humanitarian settings in their actions to counter suicide and self-harm in humanitarian contexts and to save lives.
Rev. Panam Salud Publica. 2017;41:e153. doi: 10.26633/RPSP.2017.153
Worldwide, over 6 million people are infected with Trypanosoma cruzi, the pathogen that causes Chagas disease (CD). In the Americas, CD creates the greatest burden in disability-adjusted life years of any parasitic infection. In Co...
